These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12877586)
1. A second-generation 99m technetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain. Meltzer PC; Blundell P; Zona T; Yang L; Huang H; Bonab AA; Livni E; Fischman A; Madras BK J Med Chem; 2003 Jul; 46(16):3483-96. PubMed ID: 12877586 [TBL] [Abstract][Full Text] [Related]
2. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. Meltzer PC; Blundell P; Jones AG; Mahmood A; Garada B; Zimmerman RE; Davison A; Holman BL; Madras BK J Med Chem; 1997 Jun; 40(12):1835-44. PubMed ID: 9191960 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography. Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats. Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872 [TBL] [Abstract][Full Text] [Related]
5. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents. Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494 [TBL] [Abstract][Full Text] [Related]
6. Tc-99m-labeled tropanes as dopamine transporter imaging agents. Meegalla S; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Frederick D; Kung HF Bioconjug Chem; 1996; 7(4):421-9. PubMed ID: 8853455 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter. Zou MF; Kopajtic T; Katz JL; Newman AH J Med Chem; 2003 Jul; 46(14):2908-16. PubMed ID: 12825932 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. Meegalla SK; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Kushner SA; McElgin WT; Mozley PD; Kung HF J Med Chem; 1997 Jan; 40(1):9-17. PubMed ID: 9016323 [TBL] [Abstract][Full Text] [Related]
9. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541 [TBL] [Abstract][Full Text] [Related]
10. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Kung MP; Stevenson DA; Plössl K; Meegalla SK; Beckwith A; Essman WD; Mu M; Lucki I; Kung HF Eur J Nucl Med; 1997 Apr; 24(4):372-80. PubMed ID: 9096087 [TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351 [TBL] [Abstract][Full Text] [Related]
13. Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Kung HF Nucl Med Biol; 2001 Jul; 28(5):505-8. PubMed ID: 11516695 [TBL] [Abstract][Full Text] [Related]
14. Role of dopamine transporter imaging in routine clinical practice. Marshall V; Grosset D Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877 [TBL] [Abstract][Full Text] [Related]
15. Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent. Kushner SA; McElgin WT; Kung MP; Mozley PD; Plössl K; Meegalla SK; Mu M; Dresel S; Vessotskie JM; Lexow N; Kung HF J Nucl Med; 1999 Jan; 40(1):150-8. PubMed ID: 9935071 [TBL] [Abstract][Full Text] [Related]
16. An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1. Choi SR; Kung MP; Plössl K; Meegalla S; Kung HF Nucl Med Biol; 1999 May; 26(4):461-6. PubMed ID: 10382851 [TBL] [Abstract][Full Text] [Related]
17. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Cheon KA; Ryu YH; Kim JW; Cho DY Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278 [TBL] [Abstract][Full Text] [Related]
18. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Meltzer PC; Madras BK Eur J Nucl Med; 1997 Apr; 24(4):462-3. PubMed ID: 9198580 [No Abstract] [Full Text] [Related]
19. Biological evaluation of a technetium-99m-labeled integrated tropane-BAT and its piperidine congener as potential dopamine transporter imaging agents. Kieffer DM; Vanbilloen HP; Cleynhens BJ; Terwinghe CY; Mortelmans L; Bormans GM; Verbruggen AM Nucl Med Biol; 2006 Jan; 33(1):125-33. PubMed ID: 16459268 [TBL] [Abstract][Full Text] [Related]
20. Novel tropane-based irreversible ligands for the dopamine transporter. Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]